Traditionally, drug discovery has focused on tiny compounds, but peptidic partners are increasingly demonstrating traction. This new approach embraces peptide partners combining peptides with alternative therapeutic techniques to address intricate condition mechanisms. By employing the distinctive characteristics of peptidic compounds – such as s